%0 Journal Article
%T The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.
%A Pergolizzi M
%A Bizzozero L
%A Maione F
%A Maldi E
%A Isella C
%A Macagno M
%A Mariella E
%A Bardelli A
%A Medico E
%A Marchiò C
%A Serini G
%A Di Nicolantonio F
%A Bussolino F
%A Arese M
%A Pergolizzi M
%A Bizzozero L
%A Maione F
%A Maldi E
%A Isella C
%A Macagno M
%A Mariella E
%A Bardelli A
%A Medico E
%A Marchiò C
%A Serini G
%A Di Nicolantonio F
%A Bussolino F
%A Arese M
%J J Exp Clin Cancer Res
%V 41
%N 1
%D Sep 2022 2
%M 36056393
暂无%R 10.1186/s13046-022-02465-4
%X BACKGROUND: Colorectal cancer (CRC) remains largely incurable when diagnosed at the metastatic stage. Despite some advances in precision medicine for this disease in recent years, new molecular targets, as well as prognostic/predictive markers, are highly needed. Neuroligin 1 (NLGN1) is a transmembrane protein that interacts at the synapse with the tumor suppressor adenomatous polyposis Coli (APC), which is heavily involved in the pathogenesis of CRC and is a key player in the WNT/β-catenin pathway.
METHODS: After performing expression studies of NLGN1 on human CRC samples, in this paper we used in vitro and in vivo approaches to study CRC cells extravasation and metastasis formation capabilities. At the molecular level, the functional link between APC and NLGN1 in the cancer context was studied.
RESULTS: Here we show that NLGN1 is expressed in human colorectal tumors, including clusters of aggressive migrating (budding) single tumor cells and vascular emboli. We found that NLGN1 promotes CRC cells crossing of an endothelial monolayer (i.e. Trans-Endothelial Migration or TEM) in vitro, as well as cell extravasation/lung invasion and differential organ metastatization in two mouse models. Mechanistically, NLGN1 promotes APC localization to the cell membrane and co-immunoprecipitates with some isoforms of this protein stimulates β-catenin translocation to the nucleus, upregulates mesenchymal markers and WNT target genes and induces an "EMT phenotype" in CRC cell lines CONCLUSIONS: In conclusion, we have uncovered a novel modulator of CRC aggressiveness which impacts on a critical pathogenetic pathway of this disease, and may represent a novel therapeutic target, with the added benefit of carrying over substantial knowledge from the neurobiology field.